---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-045408"
form_type: "8-K"
ticker: "ENTA"
cik: "0001177648"
company_name: "ENANTA PHARMACEUTICALS INC"
filed_at: "2021-08-23T23:59:59+00:00"
generated_at: "2026-06-29T08:19:50.780934+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Enanta Pharmaceuticals elects Yujiro S. Hata to board of directors

## Summary
- Yujiro S. Hata elected as independent director, effective August 19, 2021.
- Board expanded to seven members; Hata appointed to Compensation and Nominating & Corporate Governance committees.
- Received non-statutory stock option for 13,144 shares vesting over 36 months.
- Will receive standard non-employee director cash compensation and indemnification agreement.

## SEC filing metadata
- accession: 0001564590-21-045408
- form_type: 8-K
- ticker: ENTA
- cik: 0001177648
- company_name: ENANTA PHARMACEUTICALS INC
- filed_at: 2021-08-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1177648/000156459021045408/0001564590-21-045408-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1177648/000156459021045408/enta-8k_20210819.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-045408
- JSON: https://secwatch.observer/filing/0001564590-21-045408.json
- Plain text: https://secwatch.observer/filing/0001564590-21-045408.txt

## Key facts
- Executive change
  Yujiro S. Hata was elected as Director at ENANTA PHARMACEUTICALS INC.
  - Action: elected
  - Role: Director
  source text: The Board of Directors of Enanta Pharmaceuticals, Inc. has elected Yujiro S. Hata to serve as an independent director of the company in the class of directors whose term expires at Enanta’s 2024 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1177648/000156459021045408/0001564590-21-045408-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.